|

pioglitazone-metformin Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Minnesota1

Indications

  • Oral Leukoplakia1
  • Cancer1

Minneapolis, Minnesota1 trial

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

University of Minnesota

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.